These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20170847)

  • 1. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators.
    Vijgen J; Botto G; Camm J; Hoijer CJ; Jung W; Le Heuzey JY; Lubinski A; Norekvål TM; Santomauro M; Schalij M; Schmid JP; Vardas P
    Eur J Cardiovasc Nurs; 2010 Mar; 9(1):3-14. PubMed ID: 20170847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators.
    ; Vijgen J; Botto G; Camm J; Hoijer CJ; Jung W; Le Heuzey JY; Lubinski A; Norekvål TM; Santomauro M; Schalij M; Schmid JP; Vardas P
    Europace; 2009 Aug; 11(8):1097-107. PubMed ID: 19525498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Driving in ICD recipients - new European recommendations.
    Norekvål TM; Vijgen J
    Eur J Cardiovasc Nurs; 2010 Mar; 9(1):1-2. PubMed ID: 20170846
    [No Abstract]   [Full Text] [Related]  

  • 4. Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology": public safety issues in patients with implantable defibrillators: a scientific statement from the American Heart Association and the Heart Rhythm Society.
    Epstein AE; Baessler CA; Curtis AB; Estes NA; Gersh BJ; Grubb B; Mitchell LB; ;
    Circulation; 2007 Mar; 115(9):1170-6. PubMed ID: 17287391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addendum to "Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology". Public safety issues in patients with implantable defibrillators. A Scientific statement from the American Heart Association and the Heart Rhythm Society.
    Epstein AE; Baessler CA; Curtis AB; Estes NA; Gersh BJ; Grubb B; Mitchell LB; ;
    Heart Rhythm; 2007 Mar; 4(3):386-93. PubMed ID: 17341412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator.
    Anderson MH; Camm AJ
    Am Heart J; 1994 Apr; 127(4 Pt 2):1185-93. PubMed ID: 8160599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Driving of a motor vehicle after implantation of a cardioverter-defibrillator in malignant heart rhythm disorders. Criteria for the medical assessment of driving fitness in Europe].
    Lüderitz B; Jung W
    Dtsch Med Wochenschr; 1996 Feb; 121(5):119-23. PubMed ID: 8717193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Driving restrictions for arrhythmia patients--with special reference to the implantable cardioverter/defibrillator].
    Lüderitz B; Jung W
    Z Kardiol; 1996; 85 Suppl 6():115-21. PubMed ID: 9064955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach.
    Thijssen J; Borleffs CJ; van Rees JB; de Bie MK; van der Velde ET; van Erven L; Bax JJ; Cannegieter SC; Schalij MJ
    Eur Heart J; 2011 Nov; 32(21):2678-87. PubMed ID: 21646229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for driving after implantable cardioverter defibrillator implantation and the use of a wearable cardioverter defibrillator : Different viewpoints around the world.
    Cooper M; Berent T; Auer J; Berent R
    Wien Klin Wochenschr; 2020 Dec; 132(23-24):770-781. PubMed ID: 32435868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of implantable cardioverter defibrillator indications: comparison of guidelines in the United States and Europe.
    Steinbeck G
    J Cardiovasc Electrophysiol; 2002 Jan; 13(1 Suppl):S96-9. PubMed ID: 11843474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driving Restrictions and Early Arrhythmias in Patients Receiving a Primary-Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD) Study.
    Steinberg C; Cheung CC; Wan D; Sodhi A; Claros S; Staples JA; Philippon F; Laksman Z; Sarrazin JF; Bennett M; Plourde B; Deyell MW; Andrade JG; Roy K; Yeung-Lai-Wah JA; Molin F; Hawkins NM; Blier L; Nault I; O'Hara G; Krahn AD; Champagne J; Chakrabarti S
    Can J Cardiol; 2020 Aug; 36(8):1269-1277. PubMed ID: 32474110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines.
    Bennett M; Parkash R; Nery P; Sénéchal M; Mondesert B; Birnie D; Sterns LD; Rinne C; Exner D; Philippon F; Campbell D; Cox J; Dorian P; Essebag V; Krahn A; Manlucu J; Molin F; Slawnych M; Talajic M
    Can J Cardiol; 2017 Feb; 33(2):174-188. PubMed ID: 28034580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    Heart Rhythm; 2020 Jan; 17(1):e220-e228. PubMed ID: 31103461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers.
    Watanabe E; Abe H; Watanabe S
    J Arrhythm; 2017 Dec; 33(6):594-601. PubMed ID: 29255507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey.
    Haugaa KH; Tilz R; Boveda S; Dobreanu D; Sciaraffia E; Mansourati J; Papiashvili G; Dagres N
    Europace; 2017 Apr; 19(4):660-664. PubMed ID: 28431077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Driving following defibrillator implantation: development and pilot results from a nationwide questionnaire.
    Bjerre J; Rosenkranz SH; Christensen AM; Schou M; Jøns C; Gislason G; Ruwald AC
    BMC Cardiovasc Disord; 2018 Nov; 18(1):212. PubMed ID: 30458722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations.
    Imberti JF; Vitolo M; Proietti M; Diemberger I; Ziacchi M; Biffi M; Boriani G
    Expert Rev Med Devices; 2020 Apr; 17(4):297-308. PubMed ID: 32160800
    [No Abstract]   [Full Text] [Related]  

  • 20. Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology.
    Jung W; Anderson M; Camm AJ; Jordaens L; Petch MC; Rosenqvist M; Santini M; Lüderitz B
    Eur Heart J; 1997 Aug; 18(8):1210-9. PubMed ID: 9458413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.